According to recent reports, a University of Leicester study has revealed that screening diabetics could create cost benefits in the long ru, not to mention improving the lives of those patients screened.
A joint-funded study by the Economic and Social Research Council alongside the Medical Research Council found that screening potential diabetics for risk of type 2 diabetes or IGT (impaired glucose tolerance) and intervening early was a cost-effective treatment strategy for UK patients.
The study, published in the British Medical Journal online comes at an opportune time, as a screening programme by the Department of Health is about to be initiated. A nationwide screening programme will hopefully help in early diabetes identification and interventio, having a major impact on the type 2 diabetes epidemic in the UK.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…